MGMT and breast cancer: Even though the research findings of MGMT methylation in breast cancer have been inconsistent [117], a study showed that methylating the MGMT promoter in chemoresistant TNBC cells results in the re-sensitization to chemotherapy, implying that MGMT could be a feasible target for chemoresistant TNBC [118].